Sabrina was invited to speak at the mRNA Quality Control & Comparability Summit in Boston. This summit is part of the World RNA Series, which is a series of events disseminating information about the rapid changes in RNA-based therapeutics in order to deliver safe and effective RNA therapies to patients faster. 

This summit was intended to address the lack of standardization in quality control and evaluation processes used for mRNA medicines. This needs to be established to facilitate the rapid approval of new mRNA medicines, allowing successful treatments to make it to market faster. 

More information can be found here.